Palantir: Earnings Were Exceptional, But At 280x Forward Earnings, The Stock Is A Hold

Palantir reported a quarter so strong that CEO Alex Karp told CNBC to "forget consensus" after the numbers dropped. U.S. commercial revenue grew 149% year-over-year. Revenue surged 93% year-over-year. The stock surged roughly 8% after hours on August 3, 2026.

The business is undeniably accelerating. The question is whether a company trading at 279 times forward earnings - after already falling 29% this year - has left enough margin of error for the average investor to chase.

My rating: Hold.

What the quarter actually delivered

Palantir's Q2 2026 results, reported after the close on August 3, beat on every headline number.

Revenue came in at $1.94 billion, up 93% from roughly $1 billion a year ago and above the consensus estimate of approximately $1.80 billion. U.S. commercial revenue - the growth engine that has been carrying the stock's narrative - surged to $764 million, up 149% year-over-year and 28% quarter-over-quarter. U.S. government revenue, the legacy strength, grew 90% to $809 million.

Earnings were the sharper beat. Adjusted EPS came in at $0.41, above the $0.35 consensus. GAAP net income was $1.06 billion, or 55% of revenue, compared to $329 million, or 13 cents per share, in the year-ago quarter. That is not a modest improvement; it is an order-of-magnitude expansion in profitability.

The margin profile deserves its own sentence. GAAP operating margin was 47%. Adjusted operating margin was 62%. Adjusted free cash flow was $1.22 billion - a 63% FCF margin. Palantir's self-reported "Rule of 40" score (a SaaS metric combining revenue growth rate plus profit margin; scores above 30 are considered elite) climbed to 155%.

Palantir also closed 220 deals of at least $1 million, 98 deals of at least $5 million, and 73 deals of at least $10 million. Total contract value (the sum of all signed deals) reached $3.37 billion, up 49% year-over-year. Record-setting U.S. commercial TCV was $2.13 billion, up 153%. Remaining deal value in the U.S. commercial pipeline - the backlog of contracts not yet fully recognized as revenue - more than doubled to $6.24 billion.

The pipeline is the part that matters most going forward. A $6.2 billion commercial deal pipeline, growing 27% in one quarter, gives visibility into revenue that the market has not yet fully priced.

Management raised full-year 2026 revenue guidance to $8.15–$8.16 billion, up from the $7.65 billion to $7.66 billion range issued last quarter. That implies roughly 82% full-year growth, 10 percentage points higher than prior guidance. U.S. commercial full-year guidance was raised to over $3.42 billion, up from over $3.22 billion.

Valuation: the number the headline does not mention

Palantir's market capitalization is $301 billion. The stock trades at 132 times trailing earnings, 279 times forward earnings, and 58 times trailing sales.

To put that in context, consider the peer set.

CrowdStrike, a similarly large cybersecurity and AI-enabled software company, trades at 40 times sales. Datadog, the monitoring and analytics platform, trades at 27 times sales. Palantir's 58x sales multiple is roughly 45% above CrowdStrike and more than double Datadog. Those peers are not cheap. But Palantir is the most expensive name in the group.

The forward P/E of 279x is the starker number. At that multiple, the market is pricing in flawless execution for years. Even the 67.7% year-over-year revenue growth that shows up on the trailing metrics - impressive as it is - does not naturally justify a 279x forward earnings multiple. A stock at that price demands that every quarter matches or beats this one, for a long stretch.

The stock has fallen 29% year-to-date and is well below its 52-week high of $207.52. That decline is what makes this quarter feel like a relief rally. It is also what keeps the stock in a range where investors still feel they have something to gain. But a 29% drawdown from $207 leaves the valuation still stretched relative to what earnings can support if growth normalizes even moderately.

The PEG ratio (price-to-earnings divided by growth rate; below 1.0 is traditionally considered fair value) shows 0.46, which looks cheap on paper. But the PEG ratio is misleading here because the trailing growth rate used in the denominator is not sustainable at current scale. A company growing 93% one quarter and 67% on a trailing basis does not grow at those rates forever. The PEG is compressing the denominator of a growth rate that is peaking, not a floor.

The Karp factor: anti-token narrative, pro-open models

The earnings report landed alongside an ongoing narrative from CEO Alex Karp about the structure of the AI market. On July 1, Karp told CNBC's Squawk Box that "something has gone completely wrong" with how AI is sold through token-based pricing models used by OpenAI and Anthropic. He argued that enterprises are frustrated by rising token costs and that open-weight models - models that can be run on a company's own infrastructure rather than metered through an API - are the path forward.

Palantir positioned itself as the beneficiary. Two days before the interview, Palantir and NVIDIA announced an expanded partnership to deploy NVIDIA's open Nemotron models in sovereign environments. Karp argued that enterprises want "control over their compute, their models, their data stack and their alpha."

This is a credible strategic thesis. The token economy of the frontier AI labs is expensive, and enterprises building mission-critical applications on metered APIs face margin pressure. If Palantir captures a share of that migration, it is tailwind, not narrative.

But the narrative also serves as a sales pitch for Palantir's Sovereign AI platform. That is not a flaw - it is normal. What matters is whether the earnings prove it. The 149% commercial growth and $2.13 billion in commercial TCV suggest the demand is real and not merely rhetorical.

What would change the rating

The business metrics are strong. The balance sheet is clean - $2.29 billion in cash and equivalents, $1.64 billion in total debt, and negligible net debt exposure. Free cash flow grew 104% year-over-year to $2.69 billion on a trailing basis. Return on invested capital is 27.9%. These are the numbers of a company in a growth and profitability surge.

The constraint is the price. At 279x forward earnings, the stock has priced in years of near-perfect execution. A single quarter of 50% revenue growth instead of 90%, or a guidance cut of even a few percentage points, would compress this multiple sharply.

The rating would move to Buy if: - The stock declines to the $100-110 range, where the forward multiple compresses toward 200x and the margin of error improves - Palantir delivers two or more consecutive quarters at or above this growth trajectory, proving that 80%+ growth is sustainable at scale - Commercial revenue becomes the dominant segment, reducing dependence on government contracting cycles

The rating would move to Underweight if: - Commercial growth decelerates below 80% while the multiple remains above 200x forward earnings - The $6.2 billion commercial pipeline converts more slowly than the current burn rate suggests - Token-cost narratives fade without a corresponding lift in Palantir's own bookings

The takeaway

Palantir's Q2 2026 quarter is one of the strongest earnings prints in the large-cap software space. The commercial revenue engine is real, the margins are expanding, the pipeline is deep, and the balance sheet can weather any shock.

But strong does not mean buy at any price. At $301 billion in market cap and 279 times forward earnings, Palantir is a company priced for perfection. The 29% year-to-date decline from the 52-week high creates an illusion of value that does not exist at this level. The growth has to sustain itself for years to justify the multiple, and the market gives it very little room to slow.

Hold. Wait for a steeper discount, or for two quarters of proof that this growth rate is sticky before paying up again.